Imatinib Mesylate2020-03-13T16:39:28-01:00

Project Description

Imatinib Mesylate

Contact Us
Mechanism of action:

Tyrosine kinase inhibitor (specific for abnormal BCR-ABL tyrosine kinase produced by Philadelphia chromosome in CML/ALL)

Indications:

Acute lymphoblastic leukemia, Chronic myelogenous leukemia, Gastrointestinal stromal tumors, Dermatofibrosarcoma protuberans, Systemic mastocytosis.

Chemical Name:

methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide

Details

Molecular Weight:

589.7 g/mol

Molecular Formula:

C30H35N7O4S

 CAS:No

220127-57-1

Product Type:

Powder

Send Req

FIRST NAME *
LAST NAME *
EMAIL ADDRESS *
PHONE NUMBER

SUBJECT

HOW CAN WE HELP?